Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-12-23
2000-10-24
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 49, 514 50, 514885, A01N 4304
Patent
active
061367915
ABSTRACT:
An agent of the chemical formula C.sub.7 N.sub.3 H.sub.8 O.sub.2 R.sup.1 R.sup.2 XX.sup.1, wherein X and X.sup.1 are each independently C or N but not simultaneously, R.sup.1 is lower alkyl, alkenyl or alkynyl, halogen or haloalkyl, and R.sup.2 is H, --N.sub.3 --OH, amino or halogen; or pharmaceutically acceptable salts thereof. A method of treating a disorder associated with the overexpression of cytidine deaminase or deoxycytidine deaminase comprises administering to a subject in need of the treatment a compound of the chemical formula ##STR1## wherein X and X.sub.1 are each independently C or N; R.sup.1 is lower alkyl, lower alkenyl, lower alkynyl, halogen, or haloalkyl; and R.sup.2 H, --N.sub.3, --OH, amino, or halogen;
REFERENCES:
patent: 3891623 (1975-06-01), Vorbruggen et al.
patent: 4501744 (1985-02-01), Ogilvie
patent: 5079235 (1992-01-01), Purifoy et al.
patent: 5084445 (1992-01-01), Chu et al.
patent: 5215971 (1993-06-01), Datema et al.
patent: 5576429 (1996-11-01), Johansson et al.
patent: 5652099 (1997-07-01), Conrad
patent: 5728525 (1998-03-01), Conrad
T. Kulikowski et al.; Preparation and Properties of N.sup.4 -Alkyl Analogues of 5-Methyl-2'-Deoxycytidine, Their 5'-Mono and Triphosphates, and N.sup.4 -Alkyl Derivaties of 1,5-Dimethylcytosine, ACTA Biochimica Polonica 16:201-217 (1969).
J. J. Fox et al.; Thiation of Nucleosides. II. Synthesis of 5-Methyl-2'-deoxycytidine and Related Pyrimidine Nucleosides, 81:178-187 (1959).
T. Lin et al.; Synthesis and Biological Activity of Various 3'-Azido and 3'Amino Analogues of 5-Substituted Pyrimidine Deoxyribonucleosides, J. Med. Chem. 26, No. 12:1691-1696 (1983).
C. K. Chu et al.; Structure-Activity Relationships of Pyrimidine Nucleosides as Antiviral Agents for Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells, J. Med. Chem. 32, No. 3:612-167 (1989).
C. Kim et al.; Potential Anti-AIDS Drugs. 2',3'-Dideoxycytidine Analogues, J. Med. Chem 30:862-866 (1987).
F.D. Boudinot et al.; Pharmacokinetics and Metabolism of 3'Azido-2',3'-Dideoxy-5'-Methyl Cytidine in Rhesus Monkeys, Drug Metabolism and Disposition 21(5):855-860 (1993).
Amzel Viviana
East Carolina University
Wilson James O.
LandOfFree
Agent and method for treating disorders associated with cytidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent and method for treating disorders associated with cytidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent and method for treating disorders associated with cytidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1964152